Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-09

Outcome and Prognostic Factors in Patients with Small Cell Lung Cancer who Receive Third-line Chemotherapy

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui [...]

Tumori Journal

Retricted access

Research article

First published 2001-1

Documentation of capecitabine usage as a third-line chemotherapy option for metastatic breast cancer patients

Anupam Rajora, Katherine S Chow, Thanh T Vu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2006-9

Capecitabine and Mitomycin c May be an Effective Treatment Option for Third-line Chemotherapy in Advanced Colorectal Cancer

Mario Scartozzi, Alfredo Falcone, Francesca Pucci [...]

Tumori Journal

Retricted access

Research article

First published 1995-1

Third-Line Chemotherapy with Mitomycin C and Lonidamine in Advanced Bladder Cancer. Partial Response in a Patient with Skin and Lung Metastases

Alfredo Berruti, Alex Gerbino, Roberto Faggiuolo [...]

Tumori Journal

Open access

Research article

First published 2008

Phase II Study of S-1 Monotherapy as a First-line,Combination Therapy of S-1 plus Cisplatin as a Second-line,and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma

Yasushi Rino, Norio Yukawa, Nobuyuki Wada [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2010

A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 plus Cisplatin as a Second-line Therapy,and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report

Yasushi Rino, Norio Yukawa, Hitoshi Murakami [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 1995-7

Cisplatin and VP16 in Metastatic Breast Carcinoma as a Third-Line Chemotherapy: A Randomized Study Comparing Low versus High Doses of Cisplatin

Guido Ceci, Giancarlo Bisagni, Giorgio Cocconi [...]

Tumori Journal

Open access

Research article

First published 2024

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer

Nuoya Yu, Sha Huang, Zhe Zhang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-05

Improvement of quality of life in third-line chemotherapy with lapatinib in a case of metastatic breast cancer

Serafino Conforti, Salvatore Turano, Stefano Minardi [...]

Tumori Journal

Open access

Research article

First published 2020

Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV

Wolfgang M Brueckl, Martin Reck, Achim Rittmeyer [...]

Clinical Medicine Insights: Oncology

Search results